Measured human dosimetry of 68Ga-DOTATATE

RC Walker, GT Smith, E Liu, B Moore… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Measured human dosimetry of the 68Ga-labeled synthetic somatostatin analog 68Ga-
DOTATATE has not been reported in the peer-reviewed literature. 68Ga-DOTATATE is an …

Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors

M Sandström, I Velikyan… - Journal of Nuclear …, 2013 - Soc Nuclear Med
68Ga-DOTATOC and 68Ga-DOTATATE are 2 radiolabeled somatostatin analogs for in vivo
diagnosis of neuroendocrine tumors with PET. The aim of the present work was to measure …

Distribution pattern of 68Ga-DOTATATE in disease-free patients

M Shastry, I Kayani, D Wild, M Caplin… - Nuclear medicine …, 2010 - journals.lww.com
Purpose 68 Ga-DOTA-DPhe 1, Tyr 3-octreotate (68 Ga-DOTATATE) is a somatostatin
analogue that shows high affinity for somatostatin receptor subtype 2 (sst 2) and has been …

Long-acting somatostatin analog therapy differentially alters 68Ga-DOTATATE uptake in normal tissues compared with primary tumors and metastatic lesions

N Ayati, ST Lee, R Zakavi, K Pathmaraj… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Synthetic somatostatin analogs have been posed as a potential source of error in
somatostatin receptor imaging through interference with tumor detection; however …

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal …

Ö Ugur, PJ Kothari, RD Finn, P Zanzonico… - Nuclear medicine and …, 2002 - Elsevier
Radionuclide labeled somatostatin analogues selectively target somatostatin receptor
(SSTR)-expressing tumors as a basis for diagnosis and treatment of these tumors. Recently …

Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC

M Asti, G De Pietri, A Fraternali, E Grassi… - Nuclear medicine and …, 2008 - Elsevier
INTRODUCTION: Imaging of somatostatin receptor expressing tumours has been greatly
enhanced by the use of 68Ga-DOTATOC and PET/CT. METHODS: In this work, a purification …

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5

D Wild, HR Mäcke, B Waser, JC Reubi, M Ginj… - European journal of …, 2005 - Springer
Existing somatostatin-based radiotracers (eg 111In-DOTA TOC) have sole affinity for
somatostatin receptor subtype 2 (sst2). This represents a drawback, given that sst1–5 have …

[HTML][HTML] Somatostatin receptor PET ligands-the next generation for clinical practice

E Pauwels, F Cleeren, G Bormans… - American Journal of …, 2018 - ncbi.nlm.nih.gov
Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …

[PDF][PDF] Optimized production and quality control of 68Ga-DOTATATE

A Aghanejad, AR Jalilian, S Maus… - Iranian Journal of …, 2016 - irjnm.tums.ac.ir
Introduction: Optimized production and quality control of 68Ga-DOTATATE as an efficient
and preferable PET radiotracer for somatostatin receptor imaging in neuroendocrine tumors …

Semiquantitative analysis and characterization of physiological biodistribution of 68Ga-DOTA-TATE PET/CT

J Kunikowska, L Królicki, D Pawlak… - Clinical nuclear …, 2012 - journals.lww.com
The aim of this study was to describe the normal physiological distribution of 68 Ga-DOTA-
TATE using the SUV to reflect the density of somatostatin receptors in various organ …